Essays --

Multiple induration Multiple induration interrupts the transmission of eye impulses, resulting in a wide range of symptoms and reduced function. Comprehensive patient education about the nature and treatment of the sickness can make a big difference for these patients. Multiple sclerosis (MS) is a persistent autoresistant disease of the central nervous transcription (CNS) in which the immune system erroneously attacks the myelin sheath that protects nerve cell fibers in the brain and spinal cord. This process, which is called demyelization, leads to diminished or bemused CNS function, muscle weakness, complexity with synchronism and balance, visual disturbances, exhaustion, cognitive impairments, and an forces of associated symptoms. (Bornstein M. Miller A, Slagle S, et al. Clinical develop with COP-1 in multiple sclerosis. clinical neurology 1988 33 (suppl 2) 66-69). It obliterates the fatty myelin sheath that insulates your nerve cells. Devoid of this insulation, nerve chat is interrupted. The body then makes this worse by repairing it, and congestion the area with scribble tissue. Signals going from your brain and brain stem, such as muscle synchronization signals or visual sensation signals, are slowed greatly, or just bar off. Thus, a person afflicted with Multiple Sclerosis can experience any number of symptoms. Researchers are not sure yet as to the cause of Multiple Sclerosis. There is a type of deadlock among scientists and doctors whether its or an amalgamation of the two, with the disease being inherited, but with a viral trigger, or just a simple chemical imbalance in the loathsome system. One thing is certain, though. Several kind of defect in the immune system causes white blood cells to attack and destroy the myel... ...nical experience with COP-1 in multiple sclerosis. Neurology 1988 33(suppl 2)66-69. Ellison G, Myers LW, Mickey MR, et al. Clinical experience with azathioprine the pros. Neurology 1988 38(suppl 2)20-23. Silbe rberg DH. Azathioprine in multiple sclerosis the cons. Neurology 1988 38(suppl 2) 24-26. Hauser SL, Dawson DM, Lehrich Jr, et al. Intensive immunosuppression in progress multiple sclerosis a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasm exchange and ACTH. N Engl J Med 1983 308 173-180. Likosky WH. Experience with cyclophosphamide in multiple sclerosis the cons. Neurology 1988 38(suppl 2) 14-18. Weiner HL, Mackin GA, Orva EJ, et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis final report of the Northeast Cooperative Multiple Sclerosis intercession Group. Neurology 1991 41 1047.